2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1861055642 MD
Verify on CMS →

Alyssa Carvalho, MD

Endocrinology, Diabetes & Metabolism Physician in Seattle, Washington.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
400
Medicare Part D claims · 71 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
24%
generic claims · 66% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$154.79
2 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Alyssa Carvalho, MD filed 400 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Seattle, Washington, prescribing 24% generic.

400
Part D claims, 2023
24%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Alyssa Carvalho, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

400 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Alyssa Carvalho, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Alyssa Carvalho, MD?

Quality data not reported

NPI registry status

Active

Issued 04/17/2019

NPI 1861055642

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,871 US NPIs in this specialty

Medicare Part D claims

400 85% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Washington

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers

Washington providers
Mental Health Counselor - 8.6%Mental Health Counselor8.6%Massage Therapist - 6.5%Massage Therapist6.5%Counselor - 5.7%Counselor5.7%Behavior Technician - 4.5%Behavior Technician4.5%Pharmacist - 4%Pharmacist4%Physical Therapist - 3.6%Physical Therapist3.6%Endocrinology, Diabetes & Metabolism Physician - 0.1%Endocrinology, Diabetes & Metabolism Physician0.1%
Largest specialties in Washington (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Alyssa Carvalho, MD appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 9709 3RD AVE NE, Seattle, WA, 98115, with a listed phone of (206) 860-5414. NPI 1861055642 was issued on 04/17/2019.

Medicare Part D records for calendar year 2023 show 400 prescription claims written by this provider, covering 71 Medicare beneficiaries and totaling roughly $193K in drug spend, split 66% brand-name and 24% generic by claim count.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9709 3RD AVE NE
Seattle, WA 98115

Provider Details

NPI 1861055642
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 04/17/2019

Hospital and facility affiliations

Facilities where Alyssa Carvalho, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Optum Care Washington PLLC
Everett, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Alyssa Carvalho, MD. Source: openpaymentsdata.cms.gov.

Total received

$155

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Washington WMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Alyssa Carvalho, MD. To verify Alyssa Carvalho, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Alyssa Carvalho, MD - brand share 66.0%
Endocrinology, Diabetes & Metabolism Physician average

66% brand-name claims vs 24% generic, on 400 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

400
Total Claims
$193K
Total Drug Cost
71
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
571
Total Day Supply
16,365
Brand vs Generic
66% brand / 24% generic
Brand Drug Cost
$187K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
63.3 years
Avg HCC Risk Score
2.09
Gender Split
59% female / 41% male
Age Distribution
<65: 29, 65-74: 30, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Alyssa Carvalho, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
41
Insulin Lispro Kwikpen U-100
Insulin Lispro
28
Ozempic
Semaglutide
26
Levothyroxine Sodium
23
Hydrocortisone
18
Testosterone Cypionate
15
Jardiance
Empagliflozin
14
Metformin Hcl Er
Metformin Hcl
14
Novolog Flexpen
Insulin Aspart
13
Farxiga
Dapagliflozin Propanediol
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Alyssa Carvalho, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Alyssa Carvalho, MD's 400 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Carvalho.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Washington medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Alyssa Carvalho, MD's specialty?
Alyssa Carvalho, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Seattle, Washington. Credentials: MD.
How much does Alyssa Carvalho, MD prescribe under Medicare Part D?
In 2023, Alyssa Carvalho, MD wrote 400 Medicare Part D claims totaling $193K in drug costs for 71 beneficiaries.
Where is Alyssa Carvalho, MD located?
Alyssa Carvalho, MD is located at 9709 3RD AVE NE, Seattle, WA, 98115. Phone: (206) 860-5414.
What is Alyssa Carvalho, MD's NPI number?
Alyssa Carvalho, MD's National Provider Identifier (NPI) is 1861055642, issued on 04/17/2019.
Does Alyssa Carvalho, MD prescribe more brand-name or generic drugs?
Alyssa Carvalho, MD's prescribing is 66% brand-name and 24% generic drugs by claim count, with $187K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Alyssa Carvalho, MD prescribe most often?
Based on 2023 Medicare Part D data, Alyssa Carvalho, MD's most frequently prescribed drugs include Trulicity, Insulin Lispro Kwikpen U-100, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Alyssa Carvalho, MD accept Medicare?
Alyssa Carvalho, MD appears in CMS Medicare data with 400 Part D claims and 71 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Alyssa Carvalho, MD's credentials?
Alyssa Carvalho, MD's NPI is 1861055642 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.